NGL Fine-Chem Limited (NGLFINE) - Net Assets

Latest as of March 2026: Rs3.29 Billion INR ≈ $35.60 Million USD

Based on the latest financial reports, NGL Fine-Chem Limited (NGLFINE) has net assets worth Rs3.29 Billion INR (≈ $35.60 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs5.45 Billion ≈ $58.99 Million USD) and total liabilities (Rs2.16 Billion ≈ $23.39 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NGLFINE intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs3.29 Billion
% of Total Assets	60.35%
Annual Growth Rate	22.18%
5-Year Change	62.01%
10-Year Change	462.67%
Growth Volatility	12.37

NGL Fine-Chem Limited - Net Assets Trend (2009–2026)

This chart illustrates how NGL Fine-Chem Limited's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of NGL Fine-Chem Limited to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for NGL Fine-Chem Limited (2009–2026)

The table below shows the annual net assets of NGL Fine-Chem Limited from 2009 to 2026. For live valuation and market cap data, see NGL Fine-Chem Limited (NGLFINE) market capitalisation.

Year	Net Assets	Change
2026-03-31	Rs3.29 Billion ≈ $35.60 Million	+16.57%
2025-03-31	Rs2.82 Billion ≈ $30.54 Million	+7.54%
2024-03-31	Rs2.63 Billion ≈ $28.40 Million	+18.01%
2023-03-31	Rs2.23 Billion ≈ $24.07 Million	+9.51%
2022-03-31	Rs2.03 Billion ≈ $21.98 Million	+31.57%
2021-03-31	Rs1.54 Billion ≈ $16.70 Million	+56.08%
2020-03-31	Rs989.61 Million ≈ $10.70 Million	+7.42%
2019-03-31	Rs921.23 Million ≈ $9.96 Million	+27.87%
2018-03-31	Rs720.42 Million ≈ $7.79 Million	+23.12%
2017-03-31	Rs585.12 Million ≈ $6.33 Million	+32.34%
2016-03-31	Rs442.15 Million ≈ $4.78 Million	+34.73%
2015-03-31	Rs328.16 Million ≈ $3.55 Million	+33.70%
2014-03-31	Rs245.44 Million ≈ $2.65 Million	+22.62%
2013-03-31	Rs200.15 Million ≈ $2.16 Million	+17.01%
2012-03-31	Rs171.06 Million ≈ $1.85 Million	+6.52%
2011-03-31	Rs160.59 Million ≈ $1.74 Million	+17.66%
2010-03-31	Rs136.48 Million ≈ $1.48 Million	+24.82%
2009-03-31	Rs109.35 Million ≈ $1.18 Million	--

Equity Component Analysis

This analysis shows how different components contribute to NGL Fine-Chem Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Common Stock	Rs30.89 Million	0.94%
Other Components	Rs3.26 Billion	99.06%
Total Equity	Rs3.29 Billion	100.00%

NGL Fine-Chem Limited Competitors by Market Cap

The table below lists competitors of NGL Fine-Chem Limited ranked by their market capitalization.

Company	Market Cap
Hamilton Beach Brands Holding Co Class A NYSE:HBB	$203.49 Million
Trivium Real Estate Socimi SA MC:YTRI	$203.53 Million
Security National Financial NASDAQ:SNFCA	$203.54 Million
Go Fashion (India) Limited NSE:GOCOLORS	$203.60 Million
Next PLC LSE:NXT	$203.47 Million
KIP Real Estate Investment Trust KLSE:5280	$203.37 Million
Coca Cola HBC AG LSE:CCH	$203.37 Million
LB Semicon Inc KQ:061970	$203.13 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in NGL Fine-Chem Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 2,824,346,000 to 3,292,295,000, a change of 467,949,000 (16.6%).
Net income of 481,267,000 contributed positively to equity growth.
Dividend payments of 10,812,000 reduced retained earnings.
Other comprehensive income decreased equity by 20,929,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs481.27 Million	+14.62%
Dividends Paid	Rs10.81 Million	-0.33%
Other Comprehensive Income	Rs-20.93 Million	-0.64%
Other Changes	Rs18.42 Million	+0.56%
Total Change	Rs-	16.57%

Book Value vs Market Value Analysis

This analysis compares NGL Fine-Chem Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.71x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 172.06x to 5.71x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2009-03-31	Rs17.70	Rs3045.40	x
2010-03-31	Rs22.09	Rs3045.40	x
2011-03-31	Rs25.99	Rs3045.40	x
2012-03-31	Rs27.69	Rs3045.40	x
2013-03-31	Rs32.40	Rs3045.40	x
2014-03-31	Rs39.73	Rs3045.40	x
2015-03-31	Rs53.12	Rs3045.40	x
2016-03-31	Rs71.57	Rs3045.40	x
2017-03-31	Rs94.71	Rs3045.40	x
2018-03-31	Rs116.61	Rs3045.40	x
2019-03-31	Rs149.11	Rs3045.40	x
2020-03-31	Rs160.18	Rs3045.40	x
2021-03-31	Rs250.01	Rs3045.40	x
2022-03-31	Rs328.94	Rs3045.40	x
2023-03-31	Rs360.23	Rs3045.40	x
2024-03-31	Rs425.11	Rs3045.40	x
2025-03-31	Rs457.09	Rs3045.40	x
2026-03-31	Rs532.91	Rs3045.40	x

Capital Efficiency Dashboard

This dashboard shows how efficiently NGL Fine-Chem Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 14.62%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 9.61%
• Asset Turnover: 0.92x
• Equity Multiplier: 1.66x
Recent ROE (14.62%) is below the historical average (17.83%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	15.39%	6.83%	1.21x	1.86x	Rs5.90 Million
2010	19.82%	9.72%	1.10x	1.86x	Rs13.40 Million
2011	15.04%	6.89%	1.07x	2.05x	Rs8.10 Million
2012	6.12%	2.90%	0.97x	2.17x	Rs-6.64 Million
2013	14.53%	5.24%	1.17x	2.37x	Rs9.08 Million
2014	18.45%	5.74%	1.41x	2.28x	Rs20.74 Million
2015	25.38%	9.43%	1.33x	2.03x	Rs50.48 Million
2016	25.78%	11.84%	1.24x	1.75x	Rs69.77 Million
2017	24.34%	14.22%	0.99x	1.73x	Rs83.88 Million
2018	17.48%	11.35%	0.86x	1.79x	Rs53.89 Million
2019	21.85%	13.35%	1.06x	1.54x	Rs109.15 Million
2020	8.42%	5.60%	0.97x	1.55x	Rs-15.61 Million
2021	36.72%	21.99%	1.24x	1.35x	Rs412.73 Million
2022	24.55%	15.72%	1.15x	1.36x	Rs295.76 Million
2023	9.21%	7.37%	0.97x	1.29x	Rs-17.59 Million
2024	15.73%	12.20%	0.95x	1.35x	Rs150.54 Million
2025	7.48%	5.74%	0.85x	1.53x	Rs-71.19 Million
2026	14.62%	9.61%	0.92x	1.66x	Rs152.04 Million

Industry Comparison

This section compares NGL Fine-Chem Limited's net assets metrics with peer companies in the Drug Manufacturers - General industry.

Industry Context

Industry: Drug Manufacturers - General
Average net assets among peers: $11,967,370,485
Average return on equity (ROE) among peers: 26.27%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
NGL Fine-Chem Limited (NGLFINE)	Rs3.29 Billion	15.39%	0.66x	$203.47 Million
GlaxoSmithKline Pharmaceuticals Limited (GLAXO)	$20.07 Billion	16.78%	0.50x	$4.15 Billion
Pfizer Limited (PFIZER)	$42.03 Billion	17.19%	0.17x	$2.25 Billion
Sanofi India Limited (SANOFI)	$6.08 Billion	27.83%	0.41x	$839.48 Million
SANOFI CONS HEALTHC IND L (SANOFICONR)	$2.08 Billion	79.43%	0.66x	$1.23 Billion
SENORES PHARMACEUTICALS L (SENORES)	$365.90 Million	2.71%	0.62x	$655.14 Million
TTK Healthcare Limited (TTKHLTCARE)	$1.18 Billion	13.66%	1.33x	$134.99 Million

About NGL Fine-Chem Limited

NSE:NGLFINE India Drug Manufacturers - General

Market Cap

$203.47 Million

Rs18.81 Billion INR

Market Cap Rank

#16577 Global

#861 in India

Share Price

Rs3045.40

Change (1 day)

+3.93%

52-Week Range

Rs995.00 - Rs3109.30

All Time High

Rs3109.30